“Susceptibility analysis of mutations that confer resistance to inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)”, ACI, vol. 29, no. 2, pp. 102–119, Dec. 2022, doi: 10.31243/aci.v29i2.1845.